drug discovery company
Diverchim CRO drug discovery
research chemistry
chemical synthesis
pharmaceutical chemistry
synthesis chemistry
polymer synthesis
drug synthesis
medchem
pharmaceutical research services
process research and development
Email Address :
 
Password :
 
 
cro pharmaceutical
chemical building blocks custom chemistry library synthesis synthesis optimization
custom chemical synthesis
  News - Events  
   
 


Back

DIVERCHIM SA announces € 1 million funding to support expansion and growth

DIVERCHIM SA (Montataire, F) a leading provider in specialized chemistry services to the pharmaceutical and cosmetic industries announced today having successfully completed a €1million round of equity funding which will enable Diverchim to increase its development in new facilities close to CDG airport (F) to support its continued growth. In less than 10 years, DIVERCHIM has become the first French CRO in chemistry for life science.


The investor in this round is led by BNP Paribas Private Equity. Commenting on the deal, Diverchim’s Chief Executive Officer Jean-Louis BRAYER said: “I am very grateful for being introduced to the team at BNP Paribas Private Equity at such an important stage of development in Diverchim’s history. In a strained international economical environment, the participation of BNP Private Equity is the strongest sign to encouraging Diverchim’s management to reach these growing objectives”

Adding to this, BNP Paribas Private Equity Managing Director Bernard D’Hotelans said: “We are delighted to be involved with Diverchim and his team mixing youth and industrial experiences at this exciting stage of its development. With its excellent reputation and high quality services, we believe Diverchim is in very good position to continue to support the pharmaceutical and biotech industries in the future. We look forward to playing an active role, based on our experience of the sector, in helping the company achieve its growth and international aspirations.”


About BNP Private Equity


BNP Paribas Private Equity, trust company of funds of investments (unlisted shares) for the account of third, is a partner of BNP Paribas Investment Partners. At March 31, 2009, this activity represents a total of credits under management of 808 M€, distributed on 4 ranges of vehicles: Funds of Funds and mandates of management, the Investment funds to the Innovation, Funds of “Small Capes” (unlisted shares) and funds feeder. These activities of management are supplemented by (I) a pole of strategy and development dedicated to the creation of new activities both in France and to international while being based on the world network of BNP IP, and (II) a complete offer of services of administration of funds


Further information about the Company can be obtained at www.diverchim.com

For more information please contact:

DIVERCHIM SA

Jean-Louis BRAYER, CEO


Parc Industriel Européen “Les Marches de l’Oise”

100, rue Louis Blanc

60765 Montataire Cedex

France



Tel +33 (0)3 44 64 61 90

Fax +33(0)3 44 64 61 99